Summary
Medifoxamine is a monoamine reuptake inhibiting antidepressant drug. We have investigated its pharmacokinetics in normal healthy volunteers. After an overnight fast, ascending doses of 200, 500, 750 and 1000 mg of medifoxamine were taken orally. Plasma samples were analysed using a specific HPLC method.
Medifoxamine was well tolerated and exhibited a first order linear pharmacokinetic profile. It underwent rapid absorption and peak plasma concentrations were achieved about 1.0 h after administration. Thereafter the elimination profile was biphasic with a mean terminal half life less than 3 hours.
We found a linear relationship (r=0.80) between administered dose and AUC values for the four doses. High values were obtained for the apparent volumes of distribution and the plasma clearance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Poirier JL, Viellefond H (1986) Effects of Cledial on psychomotor performance. Psychol Med 18: 1925–1930
Leger JM, Malauzat D, Karczewski P, Pareaud M, Parmentier G, Paupry M, Saustre M (1986) Etude clinique en double avengle comparant l'activite de Cledial et de la maprotiline dans les etats depressifs. Psychol Med 18: 2295–2302
Randhawa A, Hedges A, Johnston A, Turner P (1988) A Psychopharmacological Study to Assess Anti-Muscarinic and Central Nervous Effects of Medifoxamine in Normal Volunteers. Hum Psychopharmacol 3: 195–200
Saleh S, Johnston A, Chanon M, Turner P (1989) The analysis of medifoxamine in plasma and urine by high performance liquid chromatography. J Chromatogr 496: 223–227
Johnston A, Woollard RC (1983) STRIPE: An interactive computer program for the analysis of drug pharmacokinetics. J Pharmacol Methods 9: 193–199
Scharbach H, Blanchard CH, Grivel A, Houri Z, Lachaud JD (1986) Double blind trial comparing medifoxamine versus clomipramine in neurotic reactive depression. Psychol Med 18: 1485–1493
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saleh, S., Johnston, A. & Turner, P. Medifoxamine: Oral tolerance and pharmacokinetic study in healthy human volunteers. Eur J Clin Pharmacol 39, 169–171 (1990). https://doi.org/10.1007/BF00280053
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280053